Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

LADX

LadRx (QB) (LADX)

LadRx Corporation (QB)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:LADX
DatumZeitQuelleÜberschriftSymbolFirma
14/11/202412h27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:LADXLadRx Corporation (QB)
09/10/202412h04Edgar (US Regulatory)Form 8-K - Current reportUSOTC:LADXLadRx Corporation (QB)
20/08/202412h05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:LADXLadRx Corporation (QB)
20/08/202412h03Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:LADXLadRx Corporation (QB)
14/08/202412h14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:LADXLadRx Corporation (QB)
06/06/202412h03Edgar (US Regulatory)Form 8-K - Current reportUSOTC:LADXLadRx Corporation (QB)
15/05/202412h22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:LADXLadRx Corporation (QB)
14/02/202420h49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:LADXLadRx Corporation (QB)
29/01/202422h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LADXLadRx Corporation (QB)
29/01/202422h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LADXLadRx Corporation (QB)
29/01/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LADXLadRx Corporation (QB)
29/01/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LADXLadRx Corporation (QB)
29/01/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LADXLadRx Corporation (QB)
11/01/202422h50Dow Jones NewsXoma to Make $1 Million Milestone Payment to LadRx After FDA Accepts Zevra Application for ArimoclomolUSOTC:LADXLadRx Corporation (QB)
14/11/202312h16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:LADXLadRx Corporation (QB)
12/10/202312h08Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]USOTC:LADXLadRx Corporation (QB)
11/09/202312h11Edgar (US Regulatory)Form 8-K - Current reportUSOTC:LADXLadRx Corporation (QB)
 Showing the most relevant articles for your search:USOTC:LADX